Retraction statement: Our subsequent investigators found that we were unable to repeat the results of Figure 4D and Figure 5A and B. Furthermore, conflict of interest came out after the article was published. After careful consideration, we decide to withdraw this article in order to be responsible to the readers of the journal.
. 2022 Jan 31;28(9):977. doi: 10.3727/096504021X16297183140281
Retraction notice to “miR-522-3p Promotes Tumorigenesis in Human Colorectal Cancer via Targeting Bloom Syndrome Protein” [Oncology Research 26(7) (2018) 1113–1121]
Feng Shuai
*, Bo Wang
†, Shuxiao Dong
‡
Feng Shuai
*Department of Gastroenterology, Eastern District of Linyi People’s Hospital, Linyi, Shandong, P.R. China
Find articles by Feng Shuai
Bo Wang
†Department of Pediatrics, Chinese Medicine Hospital in Linyi City, Linyi, Shandong, P.R. China
Find articles by Bo Wang
Shuxiao Dong
‡Department of Gastrointestinal Surgery, Linyi People’s Hospital, Linyi, Shandong, P.R. China
Find articles by Shuxiao Dong
*Department of Gastroenterology, Eastern District of Linyi People’s Hospital, Linyi, Shandong, P.R. China
†Department of Pediatrics, Chinese Medicine Hospital in Linyi City, Linyi, Shandong, P.R. China
‡Department of Gastrointestinal Surgery, Linyi People’s Hospital, Linyi, Shandong, P.R. China
✉
Address correspondence to Shuxiao Dong, Department of Gastrointestinal Surgery, Linyi People’s Hospital, No. 27 Jiefang Road, Lanshan District, Linyi 276000, Shandong, P.R. China. E-mail: dongshuxiao958@126.com
Collection date 2022.
Copyright © 2022 Cognizant, LLC.
This article is licensed under a Creative Commons Attribution-NonCommercial NoDerivatives 4.0 International License.
PMCID: PMC8790127 PMID: 35082021
This retracts the article "miR-522-3p Promotes Tumorigenesis in Human Colorectal Cancer via Targeting Bloom Syndrome Protein" in volume 26 on page 1113.